| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 19/12/16 | | 15:19:46 | 19 Dec 2016 | | | Directorate Change | GlaxoSmithKline PLC | RNS |
| 19/12/16 | | 09:32:43 | 19 Dec 2016 | | | Phase III study start for closed triple in asthma | GlaxoSmithKline PLC | RNS |
| 16/12/16 | | 17:32:14 | 16 Dec 2016 | | | Treasury Stock | GlaxoSmithKline PLC | RNS |
| 16/12/16 | | 10:45:58 | 16 Dec 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/12/16 | | 09:11:09 | 13 Dec 2016 | | | Audit Tender Conclusion | GlaxoSmithKline PLC | RNS |
| 12/12/16 | | 15:56:05 | 12 Dec 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/12/16 | | 15:49:13 | 2 Dec 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/12/16 | | 14:19:01 | 2 Dec 2016 | | | GSK files closed triple therapy for COPD in EU | GlaxoSmithKline PLC | RNS |
| 02/12/16 | | 07:01:39 | 2 Dec 2016 | | | Relvar Ellipta approved in Japan for COPD | GlaxoSmithKline PLC | RNS |
| 01/12/16 | | 11:00:04 | 1 Dec 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/11/16 | | 16:52:29 | 30 Nov 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 25/11/16 | | 13:35:13 | 25 Nov 2016 | | | EU submission of shingles candidate vaccine | GlaxoSmithKline PLC | RNS |
| 24/11/16 | | 11:07:20 | 24 Nov 2016 | | | Start of Phase III studies with daprodustat | GlaxoSmithKline PLC | RNS |
| 23/11/16 | | 07:05:26 | 23 Nov 2016 | | | Mepolizumab meets endpoints in phase 3 EGPA study | GlaxoSmithKline PLC | RNS |
| 21/11/16 | | 07:02:41 | 21 Nov 2016 | | | GSK files closed triple therapy for COPD in US | GlaxoSmithKline PLC | RNS |
| 18/11/16 | | 14:40:53 | 18 Nov 2016 | | | ViiV starts PhIII LA injectable treatment regimen | GlaxoSmithKline PLC | RNS |
| 16/11/16 | | 16:04:31 | 16 Nov 2016 | | | New phase III data of sirukumab for RA | GlaxoSmithKline PLC | RNS |
| 10/11/16 | | 15:09:52 | 10 Nov 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/11/16 | | 17:04:10 | 8 Nov 2016 | | | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 08/11/16 | | 17:01:58 | 8 Nov 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/11/16 | | 17:12:50 | 4 Nov 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/11/16 | | 16:49:15 | 2 Nov 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/11/16 | | 10:21:09 | 1 Nov 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 28/10/16 | | 15:17:35 | 28 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 27/10/16 | | 18:40:11 | 27 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 27/10/16 | | 13:06:45 | 27 Oct 2016 | | | GSK issues new data on shingles candidate vaccine | GlaxoSmithKline PLC | RNS |
| 26/10/16 | | 18:10:05 | 26 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 26/10/16 | | 16:41:44 | 26 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 26/10/16 | | 13:07:37 | 26 Oct 2016 | | | Second Price Monitoring Extn | GlaxoSmithKline PLC | RNS |
| 26/10/16 | | 13:02:30 | 26 Oct 2016 | | | Price Monitoring Extension | GlaxoSmithKline PLC | RNS |
| 26/10/16 | | 13:00:23 | 26 Oct 2016 | | | 3rd Quarter Results | GlaxoSmithKline PLC | RNS |
| 25/10/16 | | 15:12:30 | 25 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/10/16 | | 08:00:06 | 24 Oct 2016 | | | US FDA submission of shingles candidate vaccine | GlaxoSmithKline PLC | RNS |
| 21/10/16 | | 17:12:01 | 21 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/10/16 | | 08:00:05 | 18 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/10/16 | | 08:00:05 | 18 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/10/16 | | 08:00:05 | 18 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/10/16 | | 08:00:05 | 18 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/10/16 | | 19:28:21 | 17 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/10/16 | | 19:21:28 | 17 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/10/16 | | 19:17:32 | 17 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/16 | | 18:27:42 | 14 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/16 | | 18:13:20 | 14 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/16 | | 18:10:57 | 14 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/16 | | 18:27:43 | 12 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/10/16 | | 17:47:55 | 10 Oct 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/10/16 | | 11:03:02 | 3 Oct 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |